Association of Proton Pump Inhibitor Use with Recurrent Falls and Risk of Fractures in Older Women: A Study of Medication Use in Older Fallers
- PMID: 26728937
- DOI: 10.1007/s12603-016-0679-0
Association of Proton Pump Inhibitor Use with Recurrent Falls and Risk of Fractures in Older Women: A Study of Medication Use in Older Fallers
Abstract
Objectives: To examine the association between Proton pump inhibitors (PPIs) use and falls and fractures.
Design: A cross-sectional study.
Setting and participants: 400 female patients aged 70 years or older who were consecutively admitted to the Trauma Center Meidling, Vienna, after a fall and who required hospital admission.
Methods: We quantified the strength of the associations between PPI use and falls, and between PPI use and fractures, using a logistic regression.
Results: use of PPIs was significantly associated with risk of recurrent falls (OR 1.92, 95% CI = 1.05 - 3.50, p = 0.04) as well as with risk of a fracture (OR 2.15, 95% CI 1.10 - 4.21, p = 0.03).
Conclusions: In conclusion, our results provide further evidence that PPI use may increase risk of falls and fractures in older women and highlight the need for clinicians to reassess the original indication and the need for continuation of PPIs on a regular basis.
Similar articles
-
Long-term proton pump inhibitor therapy and falls and fractures in elderly women: a prospective cohort study.J Bone Miner Res. 2014 Nov;29(11):2489-97. doi: 10.1002/jbmr.2279. J Bone Miner Res. 2014. PMID: 24825180 Clinical Trial.
-
The effect of dose and type of proton pump inhibitor use on risk of fractures and osteoporosis treatment in older Australian women: A prospective cohort study.Bone. 2015 Dec;81:675-682. doi: 10.1016/j.bone.2015.08.024. Epub 2015 Aug 28. Bone. 2015. PMID: 26319499
-
Use of proton pump inhibitors (PPI) and history of earlier fracture are independent risk factors for fracture in postmenopausal women. The WHILA study.Maturitas. 2014 Aug;78(4):310-5. doi: 10.1016/j.maturitas.2014.05.019. Epub 2014 Jun 2. Maturitas. 2014. PMID: 24958166
-
The relationship among proton pump inhibitors, bone disease and fracture.Expert Opin Drug Saf. 2011 Nov;10(6):901-12. doi: 10.1517/14740338.2011.586628. Epub 2011 May 20. Expert Opin Drug Saf. 2011. PMID: 21599546 Review.
-
Proton pump inhibitors and risk of fracture: a systematic review and meta-analysis of observational studies.Am J Gastroenterol. 2011 Jul;106(7):1209-18; quiz 1219. doi: 10.1038/ajg.2011.113. Epub 2011 Apr 12. Am J Gastroenterol. 2011. PMID: 21483462 Review.
Cited by
-
Associations between polypharmacy and potentially inappropriate medications with risk of falls among the elderly in Saudi Arabia.BMC Geriatr. 2023 Apr 6;23(1):222. doi: 10.1186/s12877-023-03852-y. BMC Geriatr. 2023. PMID: 37024805 Free PMC article.
-
Proton-pump inhibitor use amongst patients with severe hypomagnesemia.Front Pharmacol. 2023 Jan 30;14:1092476. doi: 10.3389/fphar.2023.1092476. eCollection 2023. Front Pharmacol. 2023. PMID: 36794273 Free PMC article.
-
Chronic Proton-Pump Inhibitor Therapy and Fracture Risk in Women Aged Between 50 and 65 years: A Retrospective Case-Control Study.Cureus. 2022 Aug 26;14(8):e28429. doi: 10.7759/cureus.28429. eCollection 2022 Aug. Cureus. 2022. PMID: 36176864 Free PMC article.
-
Proton Pump Inhibitors and Bone Health: An Update Narrative Review.Int J Mol Sci. 2022 Sep 14;23(18):10733. doi: 10.3390/ijms231810733. Int J Mol Sci. 2022. PMID: 36142643 Free PMC article. Review.
-
Accuracy of Tools to Differentiate Single From Recurrent Fallers Pre-Frail Older Women.Front Public Health. 2022 May 17;10:716851. doi: 10.3389/fpubh.2022.716851. eCollection 2022. Front Public Health. 2022. PMID: 35655457 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical